Treatment · 25 March 2023
2023: What Two Old Prescriptions Tell Us
The prescriptions dated 25 March and 21 August 2023 document different medicines and Perkirol schedules. Neither date confirms when the medicines were actually taken.
By an anonymous caregiver · 3 min read
Personal experience, not medical advice. I share our family's experience here. Talk to your doctor before starting, stopping or changing any medicine. New or worsening speech trouble, facial drooping or sudden weakness can be an emergency. Seek urgent medical help immediately. Full disclaimer
A family-provided prescription dated 25 March 2023 from Prof. Dr. Md. Amirul Haque at Bangladesh Specialized Hospital adds an important correction to my father's Parkinson's history. This is a historical prescription, not his current regimen.
25 March 2023 — verified historical prescription
- Stalevo 125 mg (carbidopa + levodopa + entacapone): one tablet in the morning, one at noon and one at night (1+1+1).
- Perkirol 2 mg (ropinirole): one tablet in the morning and one at night, with none at noon (1+0+1).
21 August 2023 — second verified historical prescription
A second family-uploaded prescription from Prof. Dr. Md. Amirul Haque at Bangladesh Specialized Hospital is dated 21 August 2023. It documents a different Parkinson's prescription:
- Codopa 275 mg (carbidopa + levodopa): one tablet in the morning, one in the afternoon and one at night (1+1+1). The individual ingredient strengths have not been verified here.
- Perkirol 2 mg (ropinirole): one tablet in the morning, one in the afternoon and one at night (1+1+1).
March's document listed Stalevo 125 mg three times daily and Perkirol twice daily. August's document lists Codopa 275 mg and Perkirol, both three times daily. These are two separate dated historical records, not one unchanged schedule and not our current regimen.
How this fits with the earlier years
Father reports starting Syndopa 125 during treatment in India before his first Amirul Haque consultation around 2021. Its start date and dose frequency are unknown. The earliest medication began around Jan 2016, but that is not a confirmed Syndopa start date. The March and August 2023 prescriptions are separate dated sources; we must not present an unchanged schedule through these years.
Syndopa 125, Codopa 275 mg and Stalevo 125 mg are distinct reported brands/formulations. We do not conflate them or claim one replaced another on a known date.
What the prescription dates cannot tell us
25 March 2023 and 21 August 2023 are the exact dates on the prescriptions. They do not confirm when my father started or stopped taking either schedule, whether every prescribed dose was taken, or when any transition occurred. Changeover dates, overlap, duration and response remain unknown. The documents show what was prescribed, not a confirmed record of what was taken each day.
Keeping the record anonymous
We are sharing only the relevant historical Parkinson's medicine details. Neither scan, nor the patient's name, address, identifiers or birth details, is published or embedded. Medicines for other conditions are not included in our public Parkinson's-only list.
These recorded doses describe two past prescriptions for one person. They are not instructions for another family, and no medicine should be started, stopped or changed without the treating doctor.